News

The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for June 2, 2024. The primary purpose of the meeting is to…

Ephedrine and pseudoephedrine to be removed from the National Drug Schedules by no later than June 28, 2024.

The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on December 3-4, 2023, were finalized effective January 23, 2024.

Note: This invitation is now closed. The National Drug Scheduling Advisory Committee (NDSAC) is a committee of the National Association of Pharmacy Regulatory Authorities (NAPRA)…

The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for March 3-4, 2024 is cancelled. The next meeting of the Committee is scheduled…

Please note that the tentative meeting dates and submission deadlines for the National Drug Scheduling Advisory Committee (NDSAC) in 2024 have been updated. http://napra.ca/meeting-schedule

A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on December 3-4, 2023 with the following interim recommendations made: • Acetaminophen and…

The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for December 3-4, 2023. The primary purpose of the meeting is to…

The following are the tentative meeting dates for the National Drug Scheduling Advisory Committee (NDSAC) in 2024. http://napra.ca/meeting-schedule

The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for September 17-18, 2023, is cancelled. The next meeting of the Committee is scheduled for December…

The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on March 5, 2023 that: were finalized effective April 25, 2023. Final approval…

The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for June 11-12, 2023, is cancelled. The next meeting of the Committee is scheduled for September…